These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32286201)

  • 1. Opioid use disorder among pregnant women in the 2000-2014 North Carolina state inpatient database.
    Alemu BT; Beydoun HA; Olayinka O; Young B
    J Addict Dis; 2020; 38(3):271-279. PubMed ID: 32286201
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioid Use Disorder among Hospitalized Adults in North Carolina: Analysis from the 2000-2020 NC State Inpatient Database.
    Alemu BT; Beydoun HA; Olayinka O; Harmer B; Brown AR
    South Med J; 2024 May; 117(5):226-234. PubMed ID: 38701842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal trends in rates of opioid misuse among delivery-related hospitalizations in North Carolina from 2000 to 2014.
    Alemu BT; Beydoun HA; Olayinka O; Young B
    J Addict Dis; 2021; 39(2):270-282. PubMed ID: 33416040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent Class Analysis of Maternal Comorbid Conditions among Hospitalized Pregnant Women Diagnosed with Opioid Use Disorders in North Carolina.
    Alemu BT; Beydoun HA; Olayinka O
    Pain Physician; 2022 Jan; 25(1):E95-E103. PubMed ID: 35051156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Hospitalized Adults with Opioid Use Disorder in the United States: Nationwide Inpatient Sample.
    Alemu BT; Olayinka O; Martin BC
    Pain Physician; 2021 Aug; 24(5):327-334. PubMed ID: 34323434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance Use Disorder among Hospitalized Adolescents in North Carolina.
    Alemu BT; Young B; Beydoun HA; Olayinka O
    South Med J; 2022 Aug; 115(8):616-621. PubMed ID: 35922048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes.
    Maeda A; Bateman BT; Clancy CR; Creanga AA; Leffert LR
    Anesthesiology; 2014 Dec; 121(6):1158-65. PubMed ID: 25405293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid use disorder among hospitalized adults in North Carolina: Comparative analysis of national and statewide trends.
    Alemu BT; McCague EA; Holt N; Baron PA; Olayinka O; Martin BC
    J Opioid Manag; 2021; 17(4):343-352. PubMed ID: 34533829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States.
    Whiteman VE; Salemi JL; Mogos MF; Cain MA; Aliyu MH; Salihu HM
    J Pregnancy; 2014; 2014():906723. PubMed ID: 25254116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid-Related Disorders Among Pregnant Women with Sickle Cell Disease and Adverse Pregnancy Outcomes.
    Darlington F; Acha BM; Roshan T; Ikeanyionwu C; Kutse S; Abajue U; Osazuwa B; Gomez I; Spooner KK; Salemi JL; Dongarwar D; Olaleye OA; Salihu HM; Ndefo UA
    Pain Med; 2020 Nov; 21(11):3087-3093. PubMed ID: 32710119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Criminal Statutes for Opioid Use Disorder With Prevalence and Treatment Among Pregnant Women With Commercial Insurance in the United States.
    Gressler LE; Shah S; Shaya FT
    JAMA Netw Open; 2019 Mar; 2(3):e190338. PubMed ID: 30848807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National trends in maternal use of opioid drugs among pregnancy-related hospitalizations in the United States, 1998 to 2009.
    Salihu HM; Mogos MF; Salinas-Miranda AA; Salemi JL; Whiteman VE
    Am J Perinatol; 2015 Feb; 32(3):289-98. PubMed ID: 25077473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid Use Among HIV-Positive Pregnant Women and the Risk for Maternal-Fetal Complications.
    Nguyen NH; Le EN; Mbah VO; Welsh EB; Daas R; Spooner KK; Salemi JL; Olaleye OA; Salihu HM
    South Med J; 2020 Jun; 113(6):292-297. PubMed ID: 32483639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.
    Haight SC; Ko JY; Tong VT; Bohm MK; Callaghan WM
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(31):845-849. PubMed ID: 30091969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inpatient opioid use after vaginal delivery.
    Badreldin N; Grobman WA; Yee LM
    Am J Obstet Gynecol; 2018 Dec; 219(6):608.e1-608.e7. PubMed ID: 30171846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Maternal Opioid Use in Pregnancy With Adverse Perinatal Outcomes in Ontario, Canada, From 2012 to 2018.
    Corsi DJ; Hsu H; Fell DB; Wen SW; Walker M
    JAMA Netw Open; 2020 Jul; 3(7):e208256. PubMed ID: 32725246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017.
    Hirai AH; Ko JY; Owens PL; Stocks C; Patrick SW
    JAMA; 2021 Jan; 325(2):146-155. PubMed ID: 33433576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of drug use among pregnant women in the United States: Opioid and non-opioid illegal drug use.
    Metz VE; Brown QL; Martins SS; Palamar JJ
    Drug Alcohol Depend; 2018 Feb; 183():261-266. PubMed ID: 29310077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal opioid use disorder at delivery hospitalization in a rural state: Maine, 2009-2018.
    Gabrielson SMB; Carwile JL; O'Connor AB; Ahrens KA
    Public Health; 2020 Apr; 181():171-179. PubMed ID: 32065884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of Medicaid expansion on postpartum health care utilization among pregnant women with opioid use disorder.
    Patton BP; Krans EE; Kim JY; Jarlenski M
    Subst Abus; 2019; 40(3):371-377. PubMed ID: 30908175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.